Altered expression of autophagy-associated and mitochondrial markers in the liver of patients who died from severe pulmonary COVID-19 infection

Background Although severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) primarily affects the respiratory tract, COVID-19 may also be associated with abnormalities in extrapulmonary organs, including the liver. The mechanisms underlying hepatic involvement remain incompletely understood, particularly because angiotensin-converting enzyme 2 (ACE2), a canonical SARS-CoV-2 entry receptor, is reported to be expressed at relatively low levels in hepatocytes. This study investigated hepatic histopathological changes, the tissue distribution of SARS-CoV-2-related signals, and the expression of selected autophagy-associated markers in patients who died from severe COVID-19. Methods Liver samples obtained from patients who died from COVID-19-related respiratory failure were analyzed. Histopathological examination and immunohistochemistry were performed to assess the expression of SARS-CoV-2 proteins and autophagy-related markers, including LC3, p62, Beclin-1 and TOMM20. Fluorescent immunohistochemistry was applied to evaluate the co-localization of SARS-CoV-2 proteins with heparan sulfate. Clinical and laboratory parameters were also evaluated and compared to non-COVID-19 cohort. Results Histopathological analysis revealed variable degrees of liver alterations, including steatosis, endothelial dysfunction, sinusoidal dilatation, and fibrin deposition. Despite lacking ACE2 expression in hepatocytes, SARS-CoV-2 proteins were detected in liver tissue. Fluorescent immunostaining suggested a potential role of heparan sulfate proteoglycans in facilitating viral entry into hepatocytes. Immunohistochemical analysis revealed variable expression patterns of autophagy-associated proteins in the liver specimens, including LC3, p62/SQSTM1, and Beclin-1. Beclin-1 and the mitochondrial outer membrane protein TOMM20 showed increased immunoreactivity in the examined specimens. These findings indicate alterations in the expression of proteins associated with autophagy and mitochondrial status. Conclusions In this autopsy cohort, severe COVID-19 was associated with hepatic histopathological abnormalities and altered expression of selected autophagy-related proteins. The observed overlap between SARS-CoV-2 spike-protein signal and heparan sulfate is compatible with a possible association but does not establish that heparan sulfate mediates viral entry into hepatocytes. For the reason that static immunohistochemistry cannot directly measure autophagic flux or mitophagy, further studies using complementary functional approaches are required to determine the mechanisms underlying these findings.

Authors

Institutions

Publication Details

Journal
Frontiers in Cellular and Infection Microbiology
Published
2026-11-19
DOI
https://doi.org/10.3389/fcimb.2026.1991135
Primary Topic
COVID-19 Clinical Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Altered expression of autophagy-associated and mitochondrial markers in the liver of patients who died from severe pulmonary COVID-19 infection

Klára Werling, Katalin Dezső, Lóránd Váncza, Dávid Bárdos et al.
Frontiers in Cellular and Infection Microbiology
COVID-19 Clinical Research Studies
article

Altered expression of autophagy-associated and mitochondrial markers in the liver of patients who died from severe pulmonary COVID-19 infection

Klára Werling, Katalin Dezső, Lóránd Váncza, Dávid Bárdos, Adrián Pesti, Andrea Reszegi, Ilona Kovalszky, Attila Szíjártó, Zsuzsa Schaff, Bálint Drácz, Gábor Lotz, András Kiss
article en

Abstract

Background Although severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) primarily affects the respiratory tract, COVID-19 may also be associated with abnormalities in extrapulmonary organs, including the liver. The mechanisms underlying hepatic involvement remain incompletely understood, particularly because angiotensin-converting enzyme 2 (ACE2), a canonical SARS-CoV-2 entry receptor, is reported to be expressed at relatively low levels in hepatocytes. This study investigated hepatic histopathological changes, the tissue distribution of SARS-CoV-2-related signals, and the expression of selected autophagy-associated markers in patients who died from severe COVID-19. Methods Liver samples obtained from patients who died from COVID-19-related respiratory failure were analyzed. Histopathological examination and immunohistochemistry were performed to assess the expression of SARS-CoV-2 proteins and autophagy-related markers, including LC3, p62, Beclin-1 and TOMM20. Fluorescent immunohistochemistry was applied to evaluate the co-localization of SARS-CoV-2 proteins with heparan sulfate. Clinical and laboratory parameters were also evaluated and compared to non-COVID-19 cohort. Results Histopathological analysis revealed variable degrees of liver alterations, including steatosis, endothelial dysfunction, sinusoidal dilatation, and fibrin deposition. Despite lacking ACE2 expression in hepatocytes, SARS-CoV-2 proteins were detected in liver tissue. Fluorescent immunostaining suggested a potential role of heparan sulfate proteoglycans in facilitating viral entry into hepatocytes. Immunohistochemical analysis revealed variable expression patterns of autophagy-associated proteins in the liver specimens, including LC3, p62/SQSTM1, and Beclin-1. Beclin-1 and the mitochondrial outer membrane protein TOMM20 showed increased immunoreactivity in the examined specimens. These findings indicate alterations in the expression of proteins associated with autophagy and mitochondrial status. Conclusions In this autopsy cohort, severe COVID-19 was associated with hepatic histopathological abnormalities and altered expression of selected autophagy-related proteins. The observed overlap between SARS-CoV-2 spike-protein signal and heparan sulfate is compatible with a possible association but does not establish that heparan sulfate mediates viral entry into hepatocytes. For the reason that static immunohistochemistry cannot directly measure autophagic flux or mitophagy, further studies using complementary functional approaches are required to determine the mechanisms underlying these findings.

Frontiers in Cellular and Infection MicrobiologyVol. 16
Semmelweis University (HU)
COVID-19 Clinical Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon